ISBN/ 9781556429453
作者/出版商 Lichtenstein/Slack
出版年代/版次 2011/ 1
頁數:488 裝訂:精裝 開數:28.7*22.3 印刷:黑白 重量:1.85KG
Product Description
Ulcerative Colitis: The Complete Guide to Medical Management serves as the definitive source for medical management of ulcerative colitis (UC).
Dr. Gary R. Lichtenstein, along with Dr. Ellen J. Scherl, have collaborated with over 60 experts from around the world to provide gastroenterologists and those in training with the necessary information to successfully manage the patient with ulcerative colitis.
Sections Include:
General
The role of the FDA in drug development; pediatric considerations; disease modifiers; and more
Medications
Antibiotic use in treatment of UC; oral novel biological therapies for UC; calcineurin inhibitors use in UC; novel biologic and non-biologic therapy for UC; and more
Specific Clinical Presentations
Medical management of toxic megacolon; management of extraintestinal manifestations; medical therapy of left-sided UC; use of prebiotics and probiotics; maintenance of remission; and more
Features:
--Color images, graphs, and tables
--Extensive index that includes cross-referencing to Crohn’s Disease: The Complete Guide to Medical Management
--Comprehensive references at the end of each chapter
Organized into an easy-to-reference format, Ulcerative Colitis: The Complete Guide to Medical Management threads theory into practice and provides gastroenterology professionals with the most comprehensive information available.
The other side of inflammatory bowel disease is covered in Drs. Gary R. Lichtenstein and Ellen J. Scherl’s Crohn’s Disease: The Complete Guide to Medical Management. All gastroenterologists will find both books to be essential for future practice in the treatment and care of their patients with either Crohn’s disease or ulcerative colitis, as well as in the overall management of those with inflammatory bowel disease.
Contents
Section I: General
Chapter 1: The Natural History of Inflammatory Bowel Disease
Pietro G. Andres, MD and Lawrence S. Friedman, MD
Chapter 2: Clinical Research in Inflammatory Bowel Disease: Placebo Response in Clinical Trials
Chinyu Su, MD and James D. Lewis, MD, MSCE
Chapter 3: The Role of the FDA in Drug Development in Inflammatory Bowel Disease
Alan C. Moss, MD, FACG and Adam S. Cheifetz, MD
Chapter 4: Utility of Animal Models for the Study and Treatment of Inflammatory Bowel Disease
Ashish Chawla, MD and Kenneth Simpson, BVM&S, PhD
Chapter 5: Pediatric Considerations in Medical Therapy in Patients With Inflammatory Bowel Disease
Louis R. Ghanem, MD, PhD and Robert N. Baldassano, MD
Chapter 6: The Limitations of Applying Evidence-Based Medicine to Inflammatory Bowel Disease: What We Do Not Learn From Clinical Trials
Joshua R. Korzenik, MD and Corey A. Siegel, MD
Chapter 7: Disease Modifiers in Inflammatory Bowel Disease
Jaime A. Oviedo, MD and Francis A. Farraye, MD, MSc, FACP, FACG
Chapter 8: Fertility and Pregnancy in Inflammatory Bowel Disease
Jeffry A. Katz, MD and Vinita Elizabeth Jacob, MD
Chapter 9: Diversion Colitis
Eugeni Domènech, MD, PhD and Miguel A. Gassull, MD, PhD
Chapter 10: Medication Adherence in Inflammatory Bowel Disease
Sunanda V. Kane, MD, MSPH, FACG, FACP, AGAF
Section II: Medications
Chapter 11: General Principles of Medical Therapy of Ulcerative Colitis
Sonia Friedman, MD, FACP
Chapter 12: Assessment of Disease Activity in Ulcerative Colitis
Anthony L. Rosa, MD and Thomas A. Judge, MD
Chapter 13: Current and Future Oral Mesalamine Derivative Use in Ulcerative Colitis
Lloyd Sutherland, MDCM, MSc, FRCP(C), FACP
Chapter 14: Current and Future Topical Mesalamine Derivatives in Ulcerative Colitis
Jeffrey W. Nathanson, MD and Russell D. Cohen, MD
Chapter 15: Antibiotics in Ulcerative Colitis
Kim L. Isaacs, MD, PhD
Chapter 16: Oral and Parenteral Corticosteroids in Ulcerative Colitis
Leonard Baidoo, MD and Gary R. Lichtenstein, MD, FACP, FACG, AGAF
Chapter 17: Topical Corticosteroid Use in Ulcerative Colitis
Seymour Katz, MD, FACP, MACG
Chapter 18: 6-Mercaptopurine and Azathioprine Use in Ulcerative Colitis
Marla C. Dubinsky, MD
Chapter 19: Azathioprine Metabolism in Inflammatory Bowel Disease: A Physician’s Guide to Metabolite Testing
Carmen Cuffari, MD
Chapter 20: Methotrexate in the Treatment of Ulcerative Colitis
Ellen J. Scherl, MD, FACP, AGAF; Vinita Elizabeth Jacob, MD; Brian P. Bosworth, MD; Ryan Urquhart Warren, MD; and Harrison Lakehomer, BA
Chapter 21: Calcineurin Inhibitors (Cyclosporine, Tacrolimus, Sirolimus) and Mycophenolate Motefil Use in Ulcerative Colitis
Hans Herfarth, MD, PhD and Jürgen Schölmerich, MD, PhD
Chapter 22: Infliximab Use in Ulcerative Colitis
Wojciech Blonski, MD, PhD; Antoni Stadnicki, MD, PhD; Gary R. Lichtenstein, MD, FACP, FACG, AGAF; and Anne Burke, MD
Chapter 23: Other Tumor Necrosis Factor-Alpha Antagonists in Ulcerative Colitis
Joshua R. Korzenik, MD
Chapter 24: Novel Biological Agents for the Treatment of Ulcerative Colitis
Gert Van Assche, MD, PhD, FRCP and Paul Rutgeerts, MD, PhD, FRCP
Chapter 25: Novel Nonbiologic Therapy for Ulcerative Colitis
William J. Sandborn, MD
Section III: Specific Clinical Presentations
Chapter 26: Medical Management of Severe Ulcerative Colitis
Niraj Jani, MD and Miguel Regueiro, MD
Chapter 27: Medical Management of Toxic Megacolon in the Patient with Ulcerative Colitis
Robynne Chutkan, MD and Nabil Toubia, MD
Chapter 28: Medical Management of Ulcerative Proctitis
Philip B. Miner Jr, MD
Chapter 29: Medical Therapy of Left-Sided Ulcerative Colitis
Douglas B. Haghighi, DMD, MD and Bret A. Lashner, MD, MPH
Chapter 30: Management of Refractory Ulcerative Colitis
Edward V. Loftus Jr, MD; Ellen J. Scherl, MD, FACP, AGAF; and Melissa H. Rosen, MD
Chapter 31: Pseudointractability of Inflammatory Bowel Disease
Mansour A. Parsi, MD and Jean-Paul Achkar, MD
Chapter 32: Medical Management of Extraintestinal Manifestations of Ulcerative Colitis
Lloyd Mayer, MD and Robert Pittman, MD
Chapter 33: Nicotine and Inflammatory Bowel Disease
Truc T. Trinh, MD; Richard S. Bloomfeld, MD, MS; and Stephen J. Bickston, MD, AGAF
Chapter 34: Management of Steroid-Refractory and Steroid-Dependent Severe Ulcerative Colitis
Jesse A. Green, MD, FACG and Richard P. MacDermott, MD, FACG
Chapter 35: Prebiotics and Probiotics in Ulcerative Colitis
Robert M. Penner, BSc, MD, FRCP(C), MSc; Karen L. Madsen, PhD; Massimo Campieri, MD; and Richard N. Fedorak, MD, FRCP(C)
Chapter 36: Management of Acute and Chronic Pouchitis
James M. Becker, MD, FACS and Arthur F. Stucchi, PhD
Chapter 37: Dietary Manipulations: Oral and Enteral Nutritional Therapy for Ulcerative Colitis
Traci M. Temmen, MD and John L. Rombeau, MD
Chapter 38: Parenteral Nutrition Use in Ulcerative Colitis
Alan L. Buchman, MD, MSPH
Chapter 39: Maintenance of Remission in Ulcerative Colitis
Kenneth W. Schroeder, MD, PhD and William J. Tremaine, MD
Financial Disclosures
Index